RT Journal Article
T1 Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy
A1 Berenguer, Juan
A1 González, Juan
A1 Pulido Ortega, Federico
A1 Padilla, Belén
A1 Casado, José Luis
A1 Rubio García, Rafael
A1 Arribas, José Ramón
AB We performed a prospective study of discontinuation of secondary prophylaxis against cytomegalovirus (CMV) in 36 patients with acquired immunodeficiency syndrome and quiescent CMV retinitis after successful treatment with highly active antiretroviral therapy (HAART). No reactivation or progression of retinitis was observed in 35 patients with persistent response to HAART, findings that support the discontinuation of secondary prophylaxis against CMV retinitis in such patients.
PB Oxford University Press
SN 1058-4838
YR 2002
FD 2002-02-01
LK https://hdl.handle.net/20.500.14352/107324
UL https://hdl.handle.net/20.500.14352/107324
LA eng
NO Berenguer J, González J, Pulido F, Padilla B, Casado JL, Rubio R, Arribas JR; Madrid Group for the Study of Discontinuation of Secondary Prophylaxis in Patients with CMV Retinitis. Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy. Clin Infect Dis. 2002 Feb 1;34(3):394-7
DS Docta Complutense
RD 14 dic 2025